Cite
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.
MLA
Le, Gia Han, et al. “Spectral Signatures of Psilocybin, Lysergic Acid Diethylamide (LSD) and Ketamine in Healthy Volunteers and Persons with Major Depressive Disorder and Treatment-Resistant Depression: A Systematic Review.” Journal of Affective Disorders, vol. 355, June 2024, pp. 342–54. EBSCOhost, https://doi.org/10.1016/j.jad.2024.03.165.
APA
Le, G. H., Wong, S., Badulescu, S., Au, H., Di Vincenzo, J. D., Gill, H., Phan, L., Rhee, T. G., Ho, R., Teopiz, K. M., Kwan, A. T. H., Rosenblat, J. D., Mansur, R. B., & McIntyre, R. S. (2024). Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review. Journal of Affective Disorders, 355, 342–354. https://doi.org/10.1016/j.jad.2024.03.165
Chicago
Le, Gia Han, Sabrina Wong, Sebastian Badulescu, Hezekiah Au, Joshua D. Di Vincenzo, Hartej Gill, Lee Phan, et al. 2024. “Spectral Signatures of Psilocybin, Lysergic Acid Diethylamide (LSD) and Ketamine in Healthy Volunteers and Persons with Major Depressive Disorder and Treatment-Resistant Depression: A Systematic Review.” Journal of Affective Disorders 355 (June): 342–54. doi:10.1016/j.jad.2024.03.165.